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Introduction
Tuberculosis control requires a strong public health infrastruc-
ture to detect and treat infected people.1–8 The World Health 
Organization (WHO) has identified improved case detection 
and successful treatment as priority actions required to meet 
target levels of tuberculosis prevention and control by 2015.9 
Such improvements will require expanding surveillance 
and diagnosis services – especially among more vulnerable 
groups.10–13 Over the past two decades, global rates of case 
detection and treatment success for tuberculosis have risen 
steadily.14 However, detection and treatment remain poor in 
several countries, mostly in eastern Europe and sub-Saharan 
Africa.15
Western Europe has high rates of active case detection 
and treatment success.9 However, the 2008–2011 economic 
recession and resulting cuts in health budgets may have 
weakened tuberculosis control and prevention programmes.16 
Economic recessions are often accompanied by increases in 
drug use, homelessness, migration of vulnerable groups and 
other factors affecting the transmission of tuberculosis.17 In 
a scoping study, 27 infectious disease experts predicted that 
understaffing, recruitment freezes and reductions in the 
workforce during the recession in Europe that began in 2008 
would have a negative regional impact on the control and 
treatment of various communicable diseases.18 Tuberculosis 
was the disease most commonly cited as a cause for concern. 
Despite these concerns, several member states of the 
European Union have introduced user fees or budget cuts to 
infectious disease programmes since the onset of the reces-
sion. Between 2008 and 2010, for example, Latvia shifted ap-
proximately 50% of the costs of diagnostic testing to patients 
and reduced spending on disease control and surveillance by 
87%.19 Charges for prescription drugs were also increased in 
Ireland in 2009–2010.19 A recession may worsen the negative 
effect of payments for diagnostic tests or treatment.20,21 How-
ever, not all European countries reduced funding for com-
municable disease programmes. Estonia reduced health-care 
spending after the recession began but protected spending on 
the detection of communicable diseases. Croatia reduced user 
charges for prescription medication by 33% and both Austria 
and Germany increased their budgets for infectious disease 
prevention and control.16
Here, we test the hypothesis that the recent economic 
recession and associated reductions in public health spend-
ing resulted in declining rates of case detection and treatment 
success for tuberculosis in the European Union. We then use 
mathematical models that account for the nonlinear dynam-
ics of tuberculosis, to simulate the consequences of economic 
changes on the future trends in tuberculosis incidence, preva-
lence and mortality.
Methods
Data sources
Data on tuberculosis case detection and treatment success rates 
were taken from the 2014 edition of the WHO’s tuberculosis 
database.22 Data on total health spending, expenditure on 
public health services and gross domestic product (GDP) were 
taken from the EuroStat database.23 All macroeconomic data 
were analysed as per capita values and adjusted for inflation 
and purchasing power to facilitate comparisons across mem-
ber states of the European Union. At the time of our analysis, 
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data on public health spending were 
available for 24 of the 28 member states. 
Data were not available for Belgium, 
Greece, Romania and Slovakia because 
these member states either lack a specific 
budget line or do not report disaggre-
gated expenditure data to EuroStat. As 
we excluded Cyprus, Luxembourg and 
Malta because of their small population 
sizes, most of our final analyses were 
based on the data from 21 member states 
(available from corresponding author).
We estimated case detection rates 
as the proportion of annual tuberculosis 
incidence that was reported in case no-
tification data.22 The gap between those 
cases that are notified and those that are 
not – because they are not diagnosed or 
are diagnosed but not reported – repre-
sents the underreporting of incidence. 
The estimated rate of case detection 
may exceed 100% if the true incidence 
is underestimated and/or if cases are 
double-counted.24 Despite such issues, 
the case detection rate remains one of 
the most widely used indicators of prog-
ress in establishing effective tuberculosis 
control.1,9
For our analysis, a person with tu-
berculosis who completed a full course 
of treatment was considered to be a 
treatment success – whether there was 
evidence of a cure or not. We measured 
rates of treatment success as percentages 
of (i) new sputum-smear-positive cases, 
(ii) other new cases of tuberculosis – i.e. 
new extrapulmonary cases and new 
pulmonary cases who had been found 
sputum-smear-negative or did not have 
a sputum-smear result, and (iii) re-
treatment cases.
Statistical models
In the first step of our analysis, we quan-
tified the extent to which rates of tuber-
culosis case detection and treatment 
success changed across the European 
Union, using equation (1):
 
0 1 2TBC tt β βY β R ε= + + +  (1)
where TBC represents either the case 
detection rate or treatment success 
rate, which were estimated as separate 
models, β is a regression coefficient, t is 
the year, Y is the linear time trend in the 
case detection rate across the European 
Union, R is a binary indicator marking 
the European Union’s recession (2008–
2011) and ε is an error term. Case detec-
tion rates for the previous 12 months 
were based on the estimated proportion 
of new smear-positive cases that had 
been detected across all 21 of our study 
countries. Treatment success rates were 
estimated separately for smear-negative, 
smear-positive and re-treatment cases of 
tuberculosis.
In a subsequent step, we tested 
whether the economic downturn and/or 
reductions in public health expenditure 
could account for the observed changes 
in rates of tuberculosis case detection 
over time, using equation (2):
 
0 1 2 3TBC PH GDP Y+it it it i itβ β β β μ ε= + + + +
 (2)
where i is a country, PH is government 
expenditure on public health services 
per capita, GDP is a measure of the 
GDP per capita and µ is the country 
fixed effect. In a third step, the severity 
of recession was based on the cumulative 
decline in GDP for each country during 
the recession. For all of our econometric 
models, we adjusted for time trends and 
country-specific fixed effects. Models 
were investigated using Stata version 13 
(StataCorp. LP, College Station, United 
States of America).
Mathematical models and 
simulations
To forecast tuberculosis incidence, 
prevalence and mortality in each of our 
study countries, we applied the findings 
from the preceding econometric models 
to dynamic mathematical models of 
tuberculosis transmission and mortal-
ity. The mathematical models simulated 
longitudinal tuberculosis rates in each 
country – given the data on case detec-
tion observed before, during and after 
the financial crisis – as well as a counter-
factual scenario in which case detection 
was unaffected by either the recession or 
the related austerity.
The modelling approach we fol-
lowed was derived from standardized 
models that are commonly used in 
tuberculosis modelling and have been 
described elsewhere.25–30 Briefly, we 
included conditions of susceptibility 
to tuberculosis, recent latent infection, 
remote latent infection, active smear-
positive tuberculosis, active smear-
negative or extrapulmonary tuberculosis 
and recent recovery from tuberculosis. 
We used a Markov chain, Monte Carlo 
algorithm to simulate transmission of 
tuberculosis within each of our study 
Fig. 1. Trends in rates of tuberculosis case detection, European Union, 1991–2012
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countries. For calibration, we used the 
corresponding longitudinal trajectory 
seen in tuberculosis incidence, preva-
lence and mortality between 1990 and 
2012 (available from corresponding au-
thor). While inputting the case detection 
and treatment success rates observed for 
each country, we fitted the correspond-
ing transmission rate and time between 
symptom onset and case detection to the 
longitudinal trajectory of tuberculosis 
incidence, prevalence and mortality 
from 1990 to 2012 – ensuring an error 
of less than 5% between the model and 
observed data. We then compared the 
observed scenario in which case de-
tection rates dropped during austerity 
– including the modelled tuberculosis 
outcomes for 2013–2030 – with the 
counterfactual scenario in which case 
detection rates followed the same linear 
trends as those that occurred before the 
onset of the recession.
We used sensitivity and uncertainty 
analyses to examine the robustness of 
the modelled results.
Results
Cross-national trends
Before the recession – between 1991 
and 2007 – case detection rates were 
approaching 85% across the European 
Union. Subsequently the rate of case 
detection fell (Fig. 1). We estimated 
that case detection rates declined by a 
mean of 5.22% (95% confidence inter-
val, CI: 2.54–7.90) during the reces-
sion (Table 1). In contrast, treatment 
success rates appear to have remained 
stable in the European Union (Fig. 2). 
As the recession had no observable ef-
fect on treatment success rates among 
smear-negative, smear-positive or 
re-treatment cases, the remainder of 
this paper focuses on variations in case 
detection rates.
Effects of recession
To assess the effect of the recession 
on case detection, we evaluated two 
standard indicators of an economic 
downturn: the annual changes in GDP 
per capita (model 1, Table 2), and a 
measure of the severity of the recession 
– which was based on the cumulative 
declines in GDP per capita for each 
country (model 2, Table 2).16,31 Annual 
economic growth appeared to have no 
effect on detection rates (P = 0.60), but 
cumulative declines in GDP during the 
recession were associated with falling 
case detection rates. A cumulative fall 
in GDP per capita of 100 United States 
dollars (US$) was associated with a re-
duction of 0.22% (95% CI: 0.05–0.39) 
in the detection rate (Table 2).
Case detection rates did not decline 
in every country that experienced a 
recession. Although both Ireland and 
Portugal experienced deep recessions, the 
tuberculosis case detection rate fell in Ire-
land but not in Portugal (Fig. 3). Ireland 
implemented substantial reductions in 
public health spending whereas Portugal 
reduced its total government expenditure 
but initially protected its spending on 
public health services (Fig. 4).
To test the role of budgetary deci-
sions further, we included government 
expenditure on public health services in 
the statistical models (model 3, Table 3). 
Each US$ 100 decline in spending on 
public health services was associated 
with a decline of 3.11% (95% CI: 0.68–
5.53) in the case detection rate. The mag-
nitude of this effect was not significantly 
changed after adjusting for fluctuations 
in GDP per capita (β = 3.18%; 95% CI: 
0.88–5.48) or for cumulative declines 
in GDP per capita (β = 2.74%; 95% CI: 
0.31–5.16).
Table 1. Trends in tuberculosis case detection and treatment success rates, European Union, 1991–2012
Time period Change in case  
detection rate, % (SE)
Change in treatment success rate
Smear-negative and extrapul-
monary new cases, % (SE)
Smear-positive new 
cases, % (SE)
Re-treatment cases, % (SE)
Annual trend −0.22 (0.12) −0.56 (0.58) −0.21 (0.40) −0.10 (0.50)
2008–2011 −5.22 (1.24)** 0.94 (2.66) 2.15 (2.96) 1.57 (3.68)
SE: standard error. ** P < 0.01.
Notes: Data represent the combined values for 21 countries – i.e. all of the member states of the European Union in 2014 excluding Belgium, Cyprus, Greece, 
Luxembourg, Malta, Romania and Slovakia. Data on case detection rates and treatment success rates were available among smear-negative patients for the years 
1995–2012, extrapulmonary new cases for the years 2004–2012, smear-positive new cases for the years 2000–2012 and re-treatment cases for the years 2000–2012.
Data source: World Health Organization22 and EuroStat.23
Fig. 2. Trends in rates of tuberculosis treatment success, European Union, 1995–2012
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Role of underreporting
Since case detection reflects the gap be-
tween case notifications and estimated 
incidence, a rise in underreporting 
– which may have resulted from cuts 
in surveillance systems – may have re-
duced estimates of case detection rates. 
To test this possibility, we excluded 
Bulgaria, Hungary, Latvia, Lithuania 
and Romania from the analysis because 
they reported changes in underreport-
ing across the study period. Compared 
with the full analysis, this analysis in-
dicated a stronger association between 
public health spending and the tuber-
culosis case detection rates (β = 3.53%; 
95% CI: 1.12–5.94; Table 4 and Fig. 5).
Tuberculosis forecasting
To understand the complex longer-
term effects of the changes in case 
detection associated with the recession 
on overall tuberculosis trajectories, we 
used the results of our econometric 
analysis as inputs in a dynamic math-
ematical model of tuberculosis trans-
mission and mortality. Fig. 6 shows 
the effect of recession and austerity 
compared with a counterfactual of 
continued economic growth. Further 
sensitivity analyses around the pa-
rameter values did not change these 
findings substantially.
Robustness of models
Adjustment for nonlinear time trends 
using dummy variables for year at-
tenuated the impact of GDP – but not 
that of public health expenditure – on 
case detection (Table 5). Using treat-
ment success rates as the dependent 
variable, we repeated the statistical 
models. We found no significant as-
sociation between treatment success 
and GDP or public health spend-
ing (Table 6). After adjusting for all 
other forms of health expenditure, we 
found that the effect of public health 
expenditure on the tuberculosis case 
detection rate was attenuated slightly 
but remained statistically significant 
(Table 7). As tuberculosis in Europe 
is partly fuelled by migration, changes 
in reported tuberculosis cases may be 
attributable to population movement 
rather than to changes in case detec-
tion. Unfortunately, the data available 
on tuberculosis trends in migrants to 
the European Union are problematic as 
they often lack accurate denominators 
for the migrants’ countries of origin.32 
Adjustment of our main models for 
changes in overall levels of immigration 
during our study period did not affect 
our main findings (Table 8).
Discussion
Rates of tuberculosis case detection fell 
by about 5% across the European Union 
during 2008–2011. This reduction was 
significantly linked to the economic 
recession and to reductions in public 
health spending. Using mathematical 
models, we estimated that the combined 
shocks of a recession and reductions in 
the budgets available for case detection 
would increase tuberculosis prevalence 
and tuberculosis-attributable mortality 
by as much as 3% for more than a decade 
after the recession.
Recession and economic auster-
ity would be expected to lower case 
detection rates and therefore lead to 
an increase in tuberculosis-attributable 
mortality – since fewer tuberculosis 
patients would be detected and effec-
tively treated. In consequence, fewer 
patients would live long enough to be 
able to relapse from recovery to active 
tuberculosis or to produce secondary in-
Table 2. GDP per capita and tuberculosis case detection rates, European Union, 
1991–2012
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE)
Decline in annual GDP per capita of US$ 100 −0.79 (3.22) NA
Cumulative decline in GDP per capita of US$ 100 
(2008–2011)
NA −0.22 (0.08)*
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars. 
* P < 0.05.
Notes: Data for 21 countries – i.e. all of the member states of the European Union in 2014 except Belgium, 
Cyprus, Greece, Luxembourg, Malta, Romania and Slovakia – and 316 country-years. Standard errors were 
adjusted for repeated observations within countries. Adjusted for country differences that were constant 
over time and for linear time trends.
Data source: World Health Organization22 and EuroStat.23
Fig. 3. Rates of tuberculosis case detection, Ireland and Portugal, 2000–2012
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cident cases and tuberculosis incidence 
would be relatively low. However, any 
short-term decline in incidence would 
soon be replaced by a rise in reported 
incidence as more – undetected – latent 
cases infect others. In the long term, the 
rise in prevalent cases would lead to 
higher incidence.
Our study has several important 
limitations. First, missing data meant 
that we had to exclude Greece – and 
some other European countries that 
reduced health-care spending during 
the recession – from our analysis.33 
However, exclusion of these countries 
probably led to the associations we 
observed appearing weaker than they 
might otherwise have done. Second, as 
case detection rates are estimated as the 
ratio between case notifications and the 
estimated incidence, our main depen-
dent variable may have been affected 
by measurement error. However, errors 
in the estimation of underreporting 
should not bias our attempts to observe 
potential associations between short-
term economic changes and fluctua-
tions in the rates of the detection and 
successful treatment of tuberculosis. 
When we excluded those countries 
where estimated levels of underreport-
ing were known to have fluctuated 
over time, our main findings remained 
unaltered. Third, the indicator we used 
for public health expenditure was not 
restricted to tuberculosis-related ex-
penditure but also included spending 
on the prevention of other diseases and 
the operation of other health services. 
Again, this limitation may have reduced 
the apparent strength of the observed 
associations. Fourth, the WHO’s esti-
mates of tuberculosis prevalence are 
revised annually and may be subject 
to retrospective adjustment– but any 
changes are unlikely to alter the main 
implications of our findings. Fifth, while 
changes in diagnostic practices in some 
countries – e.g. moving towards meth-
ods of laboratory confirmation other 
than smear positivity – may influence 
tuberculosis case detection rates, such 
changes are generally slow and unlikely 
to create short-term fluctuations in case 
detection. Sixth, reductions in public 
health expenditure did not explain all 
of the variation in case detection rates. 
One other possible explanation is that 
case detection fell as a result of delays 
in seeking treatment – delays that were 
not captured in our statistical models.24 
Future research is needed to understand 
the policy decisions behind the cuts we 
observed in public health expenditure 
and to link them to changes in case de-
tection and other health outcomes.18,19 
Reductions in public health expenditure 
have often been coupled with erosion 
of social safety nets.34,35 More work is 
needed to understand how these aspects 
of austerity may affect tuberculosis 
incidence and treatment success.15,36–38
Mathematical models revealed the 
potential short- and long-term effects 
of recessions and austerity on tuber-
culosis case detection. We found that 
inadequate detection and treatment can 
lead, in the short-term, to declines in 
Fig. 4. Expenditure on public health services, European Union, 2009–2011
Percentage change in public health spending, 2009–2011
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Note: The relevant data for Belgium, Greece, Romania, Slovakia and Spain were not available.
Data source: EuroStat.23
Table 3. Expenditure on public health and tuberculosis case detection rates, European 
Union, 1991–2012
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE) Model 3, % (SE)
Increase in public health spending of 
US$ 100 per capita
3.11 (1.16)* 3.18 (1.10)** 2.74 (1.16)*
Fall in annual GDP per capita of 
US$ 100
NA −1.21 (3.06) NA
Cumulative fall in GDP per capita of 
US$ 100 during recessionary years of 
2008–2011
NA NA −0.21 (0.08)*
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars. 
* P < 0.05; ** P < 0.01.
Notes: Data for 21 countries – i.e. all of the member states of the European Union in 2014 except Belgium, 
Cyprus, Greece, Luxembourg, Malta, Romania and Slovakia – and 316 country-years. Standard errors were 
adjusted for repeated observations within countries. Adjusted for country differences that were constant 
over time and for linear time trends.
Data source: World Health Organization22 and EuroStat.23
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the number of people alive to relapse or 
transmit the disease – artificially deflat-
ing the incidence. However, if low rates 
of case detection persist, new prevalent 
cases can become more abundant and 
increase tuberculosis incidence. High 
incidence can then lead to elevated 
case-loads and mortality levels that can 
persist for over a decade beyond the 
period of recession and austerity.
Our simulation models cannot 
capture all of the complex changes that 
occur during a recession. As crowd-
ing and other behaviours that increase 
contact rates may become more frequent 
during recessions, our model of trans-
mission may underestimate the impact 
of recession and/or budgetary austerity 
on tuberculosis outcomes.
Tuberculosis control is sometimes 
seen as a soft target for spending cuts.39 
Many of the infectious disease experts 
that we interviewed in a previous study 
were concerned that European govern-
ments would focus any recession-related 
reductions in health spending on tuber-
culosis control initiatives.18 Indeed, this 
Table 4. Expenditure on public health and tuberculosis case detection rates, European Union, 1991–2012, in countries where 
underreporting of cases appeared stable
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE) Model 3, % (SE)
Increase in public health spending of US$ 100 per capita 3.53 (1.14)** 3.54 (1.12)** 3.05 (1.13)*
Decline in annual GDP per capita of US$ 100 NA 0.44 (3.60) NA
Cumulative decline in GDP per capita of US$ 100 during 
recessionary years of 2008–2011
NA NA −0.26 (0.09)*
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars. * P < 0.05; ** P < 0.01.
Notes: Data for 17 countries: all of the member states of the European Union in 2014 except the countries with varying levels of underreporting – i.e. Bulgaria, Hungary, 
Latvia, Lithuania and Romania – and Belgium, Cyprus, Greece, Luxembourg, Malta and Slovakia. They also represent 267 country-years. Standard errors were adjusted 
for repeated observations within countries. Adjusted for country differences that were constant over time and for linear time trends.
Data source: World Health Organization tuberculosis database22 and EuroStat.23
Fig. 5. Rates of tuberculosis case detection in countries with apparently stable levels of 
underreporting, European Union, 1991–2012
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Note: Bulgaria, Hungary, Latvia, Lithuania, Luxembourg and Romania were excluded because they 
reported varying levels of underreporting over the study period.
Data source: World Health Organization.22
Table 5. Expenditure on public health and tuberculosis case detection rates, European Union, (1991–2012): effect of adding dummy 
variables for year 
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE) Model 3, % (SE)
Increase in public health spending of US$ 100 per capita 3.21 (1.12)** 3.47 (0.87)** 3.21 (1.17)*
Decline in annual GDP per capita of US$ 100 NA 4.64 (4.42) NA
Cumulative decline in GDP per capita of US$ 100 during 
recessionary years of 2008–2011
NA NA 0.01 (0.20)
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars. * P < 0.05; ** P < 0.01.
Notes: Data for 21 countries – i.e. all of the member states of the European Union in 2014 except Belgium, Cyprus, Greece, Luxembourg, Malta, Romania and Slovakia – 
and 316 country-years. Standard errors were adjusted for repeated observations within countries. Adjusted for country differences that were constant over time and for 
linear time trends.
Data source: World Health Organization22 and EuroStat.23
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Fig. 6. Simulating tuberculosis transmission and mortality, European Union, 2007–2030
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Table 6. Public health services, GDP per capita and treatment success rates for tuberculosis, European Union, 1991–2012
Covariate Change in treatment success rate
Model 1, % (SE) Model 2, % (SE) Model 3, % (SE)
Smear-negative and extrapulmonary new casesa
Increase in public health spending of US$ 100 per capita 4.24 (3.72) 4.34 (3.50) 4.34 (3.48)
Decline in annual GDP per capita of US$ 100 NA 0.02 (0.05) NA
Cumulative decline in GDP per capita of US$ 100 during recessionary 
years of 2008–2011
NA NA 0.08 (0.13)
Smear-positive new casesb
Increase in public health spending of US$ 100 per capita 0.27 (0.57) 0.37 (0.59) 0.67 (0.75)
Decline in annual GDP per capita of US$ 100 NA 0.04 (0.05) NA
Cumulative decline in GDP per capita of US$ 100 during recessionary 
years of 2008–2011
NA NA 0.18 (0.13)
Re-treatment casesc
Increase in public health spending of US$ 100 per capita 3.22 (3.53) 3.14 (3.50) 3.32 (3.61)
Decline in annual GDP per capita of US$ 100 NA −0.02 (0.07) NA
Cumulative decline in GDP per capita of US$ 100 during recessionary 
years of 2008–2011
NA NA 0.04 (0.13)
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars.
a  Based on data from 18 countries and 126 country-years.
b  Based on data from 19 countries and 216 country-years.
c  Based on data from 19 countries and 201 country-years.
Notes: Standard errors were adjusted for repeated observations within countries. Adjusted for country differences that were constant over time and for linear time 
trends.
Data source: World Health Organization tuberculosis database22 and EuroStat.23
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concern has been borne out as some 
governments have substantially reduced 
their spending on public health services 
and communicable disease control in 
recent years.
Declines in the case detection rate 
cause delays in tuberculosis detection 
and treatment. The European Centre 
for Disease Prevention and Control 
estimates that people with active and 
untreated tuberculosis may infect 10–15 
people per year on average.40 By reduc-
ing case detection rates, short-term 
budgetary reductions can increase 
long-term treatment costs. In the 
United States of America, tuberculosis 
budgets were reduced in the aftermath 
of the 1970s fiscal crisis. There was an 
initial saving of US$ 100 million but a 
subsequent outbreak of drug-resistant 
tuberculosis ultimately cost more than 
US$ 1 billion to contain.41
In conclusion, our analyses provide 
evidence that recession can lead to 
short-term reductions in the financial 
support of programmes for tuberculosis 
control. The associated decrease in the 
detection of tuberculosis is projected to 
result in sustained, long-term rises in 
tuberculosis incidence, prevalence and 
mortality. ■
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Table 8. Effect of adjusting for immigration in estimating the effects of changes in public health spending on tuberculosis case 
detection rates, European Union, 1991–2012
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE) Model 3, % (SE)
Increase in public health spending of US$ 100 per capita 3.11 (1.16)* 2.94 (1.10)* 2.73 (1.26)*
Decline in annual GDP per capita of US$ 100 NA −0.04 (3.98) NA
Cumulative decline in GDP per capita of US$ 100 during 
recessionary years of 2008–2011
NA NA −0.22 (0.08)*
1% increase in immigration NA 1.58 (1.20) 1.21 (1.15)
GDP: gross domestic product; NA: not included in model; SE: standard error; US$: United States dollars. * P < 0.05.
Notes: Data for 21 countries – i.e. all of the member states of the European Union in 2014 except Belgium, Cyprus, Greece, Luxembourg, Malta, Romania and Slovakia – 
and either 316 country-years (model 1) or 245 country-years (models 2 and 3). Standard errors were adjusted for repeated observations within countries. Adjusted for 
country differences that were constant over time and for linear time trends.
Data source: World Health Organization tuberculosis database22 and EuroStat.23
Table 7. Expenditure on public health, other government health spending, and tuberculosis detection rates, European Union, 1991–
2012
Covariate Change in case detection rate
Model 1, % (SE) Model 2, % (SE)
Increase in public health spending of US$ 100 per capita 3.11 (1.16)* 2.62 (1.03)*
Increase in government health spending, excluding public health, of US$ 100 per 
capita
NA −0.54 (0.42)
NA: not included in model; SE: standard error; US$: United States dollars. * P < 0.05.
Notes: Data for 21 countries – i.e. all of the member states of the European Union in 2014 except Belgium, Cyprus, Greece, Luxembourg, Malta, Romania and Slovakia – 
and 316 country-years. Standard errors were adjusted for repeated observations within countries. Adjusted for country differences that were constant over time and for 
linear time trends.
Data source: World Health Organization tuberculosis database22 and EuroStat.23
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摘要
结核病控制和经济衰退 : 一项针对 1991 - 2012 年期间在 21 个国家采集的数据而开展的纵向研究
目的 旨在调查欧盟国家的经济衰退是否会影响对结核
病的控制。
方法 基于从 21 个欧盟成员国采集的数据 (1991 – 
2012 年 ), 多元回归模型用以量化国内生产总值、公共
卫生支出和结核病例检测率之间的联系。因经济衰退
引起的发病病例中的预估变化与结核病传染的数学模
型结合起来 , 可预测出经济衰退在 2030 年前对结核病
流行病学的潜在影响。
结果 在 1991 年至 2007 年期间 , 欧盟国家的痰涂片阳
性结核病检测率大概稳定在 85%。在经济衰退 (2008 
– 2011 年 ) 期间 , 检测率平均下降了 5.22%(95% 置
信区间 ,CI:2.54 - 7.90), 但是治疗成功率并无显著变化 
(P = 0.62)。人均经济产量降低 100 美元与结核病例检
测率平均下降 0.22% (95% CI:0.05 - 0.39) 相关。公共
卫生服务方面的支出降低同等金额与检测率平均下
降 2.74% (95% CI:0.31 – 5.16) 相关。数学模型表明 , 经
济衰退和随之而来的紧缩政策将导致结核病发病率增
加 , 而由结核病引起的死亡率预计会持续十多年的时
间。
结论 在整个欧盟中 , 公共卫生服务的支出减少导致结
核病例的检测率降低 , 从而促使疾病复发的长期风险
提高。
Résumé
Lutte antituberculeuse et récession économique : étude longitudinale des données de 21 pays européens pour la période de 
1991 à 2012
Objectif Enquêter pour déterminer si la récession économique a affecté 
la lutte antituberculeuse dans l’Union européenne.
Méthodes Des modèles de régression multivariée ont été utilisés pour 
quantifier l’association entre le produit intérieur brut, les dépenses de 
santé publique et les taux de détection des cas de tuberculose, à partir 
de données provenant de 21 États membres de l’Union européenne 
(période de 1991 à 2012). Les changements estimés dans la détection 
des cas de tuberculose imputables à la récession ont été combinés à 
des modèles mathématiques de transmission de la tuberculose afin de 
faire des projections concernant l’influence potentielle de la récession 
sur l’épidémiologie de la tuberculose jusqu’à 2030.
Résultats Entre 1991 et 2007, les taux de détection des cas de 
tuberculose à frottis d’expectoration positif dans l’Union européenne 
sont restés stables, à environ 85 %. Pendant la récession économique 
(de 2008 à 2011), les taux de détection ont baissé en moyenne de 
5,22 % (intervalle de confiance de 95 %, IC : 2,54–7,90), mais les taux 
de réussite des traitements n’ont connu aucun changement significatif 
(P = 0,62). Une baisse de la production économique de 100 dollars 
US par habitant a été associée à une réduction moyenne du taux de 
détection des cas de tuberculose de 0,22 % (intervalle de confiance 
de 95 %, IC : 0,05–0,39 ). Une réduction équivalente dans les dépenses 
consacrées aux services de santé publique a été associée à une réduction 
moyenne du taux de détection de 2,74 % (intervalle de confiance de 
95 %, IC : 0,31–5,16 ). Les modèles mathématiques suggèrent que la 
récession et les politiques d’austérité qui en ont résulté entraîneront 
des augmentations de la prévalence de la tuberculose et de la mortalité 
imputable à la tuberculose qui, d’après les projections réalisées, devraient 
durer pendant plus de dix ans.
Conclusion Dans l’Union européenne, les réductions des dépenses 
consacrées aux services de santé publique ont fait décliner la détection 
des cas de tuberculose et ont majoré le risque à long terme de 
résurgence de cette maladie.
صخلم
 1991 ماع ينب ام ةترفلا في ،اًيبوروأ اًدلب 21 نم ةدراولا تانايبلل ةينلاوط ةسارد :يداصتقلاا دوكرلاو لسلا ةحفاكم
2012 ماع لىإ
 ةحفاكم لىع يرثأت يداصتقلاا دوكرلل ناك اذإ ام ءاصقتسا ضرغلا
.بيورولأا داتحلاا في لسلا
 ديدحتل  تايرغتلما  ةددعتم  فّوتح  جذمان  تمدختسا  ةقيرطلا
 ةحصلا لىع قافنلإاو ،لياجملإا ليحلما جتانلا ينب ام ةيمكلا ةقلاعلا
 مادختساب  كلذو  ،لسلا  تلااح  فاشتكا  تلادعمو  ،ةيمومعلا
 في( بيورولأا داتحلاا في ءاضعلأا لودلا نم 21 نم ةذوخأم تانايب
 ةردقلما تايرغتلا جمد مت .)2012 ماع لىإ 1991 ماع ينب ام ةترفلا
 ةيضايرلا  جذمانلا  عم  دوكرلا  لىإ  ىزعت  يتلا  تلاالحا  فاشتكا  في
 لسلا تايئابو لامج في دوكرلل لمتحلما يرثأتلا زاربلإ ،لسلا ةياسرل
 .2030 ماع ىتح
 تلادعم تناك ،2007و 1991 يماع ينب ام ةترفلا في جئاتنلا
 ةرقتسم بيورولأا داتحلاا في مغلبلا - ةخاطلل بيايجلإا لسلا فاشتكا
 ينب ام ةترفلا في( يداصتقلاا دوكرلا للاخ .اًبيرقت 85% ةبسن دنع
 ةبسنب فاشتكلاا تلادعم تضفخنا ،)2011 ماع لىإ 2008 ماع
–2.54 :95% اهرادقم ةيحجرأ ةبسنب( طسوتلما في 5.22% تغلب
 هب  دتعُي  يرغت  يأ  جلاعلا  حاجن  تلادعم  رهظت  لم  نكلو  )7.90
 يداصتقلاا لصالحا طوبه طبتراو .)0.62 = لماتحلاا( اًيئاصحإ
 ضافخنا  طسوتم  عم  دحاولا  درفلل  يكيرمأ  رلاود  100  رادقمب
 في  )0.39–0.05 :95% اهرادقم  ةيحجرأ  ةبسنب(  0.22%  غلبي
 قافنلإا في ئفاكلما طوبلها طبترا .لسلا تلااح فاشتكا تلادعم
 طسوتلما في هتبسن تغلب ضافخناب ةيمومعلا ةيحصلا تامدلخا لىع
 في  )5.16–0.31 :95% اهرادقم  ةيحجرأ  ةبسنب(  2.74%
 أشني امو دوكرلا نأ لىإ ةيضايرلا جذمانلا يرشت .فاشتكلاا تلادعم
 تلادعم في تادايز لىإ يدؤتس ةئشانلا فشقت تاسايس نم هنع
 نأ  عقوتلما  نم يتلاو لسلا  لىإ  ىزعت يتلا  تايفولاو لسلا  راشتنا
.دقع نم رثكلأ رمتست
 ضافخنا نأ ودبي  ،بيورولأا داتحلاا ءاحنأ عيجم في جاتنتسلاا
 ضافخنا  في  يرثأت  هل  ةيمومعلا  ةيحصلا  تامدلخا  لىع  قافنلإا
 لىع ضرلما روهظ ةدوع نم رطلخا ةدايزو لسلا تلااح فاشتكا
.ليوطلا ىدلما
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Резюме
Борьба с туберкулезом на фоне экономического спада: долгосрочное исследование данных из 
21 европейской страны, 1991–2012 гг.
Цель Определить, повлиял ли экономический спад на борьбу с 
туберкулезом в Европейском союзе.
Методы Использовались многомерные регрессионные модели 
для количественной оценки связи между объемом валового 
внутреннего продукта, расходами на здравоохранение и 
показателями выявления туберкулеза на основе данных из 
21 страны-члена Европейского союза (1991–2012 гг.). Оцененные 
изменения в количестве выявляемых случаев заболевания, 
связанные с экономическим спадом, были скомбинированы с 
математическими моделями распространения туберкулеза с 
целью определения потенциального влияния экономического 
кризиса на эпидемиологию туберкулеза до 2030 года.
Результаты В 1991–2007 гг. показатель обнаружения туберкулеза 
легких у мокротопозитивных больных в Европейском союзе 
был стабильным и составлял примерно 85%. Во время 
экономического спада (2008–2011 гг.) уровень обнаружения 
снизился в среднем на 5,22% (95% доверительный интервал, ДИ: 
2,54–7,90), но при этом процент успеха в лечении существенно 
не изменился (P = 0,62). Падение объемов производства в 
размере 100 долларов США на душу населения было связано 
со средним снижением показателя частоты выявления случаев 
туберкулеза, составившим 0,22% (95% ДИ: 0,05–0,39). Аналогичное 
падение расходов на здравоохранение было связано со 
средним снижением показателя выявления, составившим 2,74% 
(95% ДИ: 0,31–5,16). Математические модели показывают, что 
экономический спад и последующая политика жесткой экономии 
приведут к увеличению распространенности туберкулеза и 
смертности от этого заболевания. Согласно прогнозам, это 
увеличение продлится в течение более десяти лет.
Вывод Сокращение расходов на здравоохранение в 
Европейском союзе, по-видимому, повлияло на уменьшение 
показателя выявления случаев туберкулеза и увеличение 
долгосрочного риска, связанного с возобновлением высокого 
уровня заболеваемости.
Resumen
Control de la tuberculosis y recesión económica: estudio longitudinal de datos de 21 países europeos, de 1991 a 2012
Objetivo Investigar si la recesión económica ha afectado al control de 
la tuberculosis en la Unión Europea.
Métodos Se utilizaron modelos de regresión multivariados para 
cuantificar la asociación entre el producto interior bruto, el gasto en salud 
pública y las tasas de detección de casos de tuberculosis a partir de los 
datos de 21 estados miembro de la Unión Europea (1991 – 2012). Los 
cambios estimados en la detección de casos atribuibles a la recesión se 
combinaron con modelos matemáticos de transmisión de la tuberculosis 
para proyectar la influencia potencial de la recesión en la epidemiología 
de la tuberculosis hasta el 2030.
Resultados Entre 1991 y 2007, las tasas de detección de la tuberculosis 
con resultado positivo en el análisis de esputo en la Unión Europea se 
mantuvieron estables en torno al 85%. Durante la recesión económica 
(2008-2011), las tasas de detección se redujeron en un promedio del 
5,22% (intervalo de confianza, IC, del 95%: 2,54-7,90), pero las tasas 
de éxito en el tratamiento no mostraron ningún cambio significativo 
(P = 0,62). Una caída en los resultados económicos de 100 dólares 
estadounidenses per cápita fue asociada a una reducción media del 
0,22% (IC del 95%: 0,05-0,39) en la tasa de detección de casos de 
tuberculosis. Una caída equivalente en el gasto en los servicios de 
salud pública se asoció a una reducción media del 2,74% (IC del 95%: 
0,31-5,16) en la tasa de detección. Los modelos matemáticos sugieren 
que la recesión y las políticas de austeridad consiguientes conducirán 
a un aumento de la prevalencia de la tuberculosis y de la mortalidad 
atribuible a esta enfermedad que se espera que persista durante más 
de una década.
Conclusión En la Unión Europea, los recortes en el gasto en servicios 
de salud pública parecen haber reducido la detección de casos de 
tuberculosis y haber incrementado el riesgo a largo plazo de un 
resurgimiento de la enfermedad.
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